Business Description:
Resmed Inc. (RMD) is a global company involved in the development, manufacturing and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. RMD sells a broad range of products in more than 70 countries worldwide through direct offices and a network of distributors.

Strategy Analysis:
RMD develops medical devices to treat patients with breathing disorders. It focuses primarily on sleep apnea and aims to educate the public and physicians about the negative effects of this problem. The firm continually upgrades its devices to improve patient experiences. RMD uses acquisitions to fill out its distribution network and product set. ResMed Inc. reported NPAT up 19% to US$226.99m for the year ended 30 June 2011. Revenues from ordinary activities were US$1.24bn, up 14% from last year. The increase in net revenue was attributable to an increase in unit sales of the Company's flow generators, masks and accessories. Diluted EPS was 1.44 cents compared to 1.23 cents last year. Net operating cash flow was $283.19m compared to $188.21m last year. No dividend was declared.